计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Y332775-1mg |
1mg |
现货 ![]() |
| |
| Y332775-5mg |
5mg |
现货 ![]() |
| |
| Y332775-10mg |
10mg |
现货 ![]() |
| |
| Y332775-25mg |
25mg |
现货 ![]() |
| |
| Y332775-50mg |
50mg |
现货 ![]() |
|
| 英文别名 | 2-[(2E)-2-(1-azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethoxy]-9H-carbazole, monohydrochloride |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | YM-53601 |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 产品介绍 |
YM-53601抑制大鼠肝微粒体和人HepG2细胞中的角鲨烯合成酶活性。YM-53601还可以抑制胆固醇的生物合成(ED | 50 | = 32 mg / kg),从而降低血浆中的胆固醇和甘油三酸酯水平。诸如YM-53601之类的化合物的降脂特性使它们成为替代HMG-CoA还原酶抑制剂/贝特类药物治疗替代品的有趣研究机会。 YM-53601 inhibits squalene synthetase activity in rat hepatic microsomes and human HepG2 cells. YM-53601 can also inhibit cholesterol biosynthesis (ED|50|= 32 mg/kg), causing a reduction in both cholesterol and triglyceride levels in plasma. The lipid-lowering properties of compounds such as YM-53601 make them interesting research opportunities for alternatives to combination HMG-CoA reductase inhibitor/fibrate therapy. |
| 纯度 | ≥98% |
| IC50 | Squalene synthase activity: IC₅₀= 79 nM (human Hep-G2 cells); Squalene synthase activity: IC₅₀= 90 nM (rat hepatIC₅₀IC₅₀somes) |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 2-[2-(1-azabicyclo[2.2.2]octan-3-ylidene)-2-fluoroethoxy]-9H-carbazole;hydrochloride |
| INCHI | 1S/C21H21FN2O.ClH/c22-19(18-12-24-9-7-14(18)8-10-24)13-25-15-5-6-17-16-3-1-2-4-20(16)23-21(17)11-15;/h1-6,11,14,23H,7-10,12-13H2;1H |
| InChi Key | JWXYVHMBPISIJQ-UHFFFAOYSA-N |
| Smiles | C1CN2CCC1C(=C(COC3=CC4=C(C=C3)C5=CC=CC=C5N4)F)C2.Cl |
| Isomeric SMILES | C1CN2CCC1C(=C(COC3=CC4=C(C=C3)C5=CC=CC=C5N4)F)C2.Cl |
| PubChem CID | 9907532 |
| 分子量 | 372.86 |
| 溶解性 | Soluble in ethanol (~2 mg/ml), DMSO (22 mg/ml), DMF (~20 mg/ml), and 1:3 solution of DMSO:PBS(pH7.2) (~0.25 mg/ml). |
|---|---|
| 敏感性 | 对湿度敏感 |
| 折光率 | n20D~1.69 (Predicted) |
| 熔点 | 236.5-237.2° C |
| 预防措施声明 |
P264: 处理后要彻底洗手。 |
|---|---|
| WGK Germany | 3 |